Eyecare company Bausch + Lomb (NYSE:BLCO) reported in Q4 CY2024, with sales up 9.1% year on year to $1.28 billion. On the ...

Eye Care Experts at Bausch and Lomb: For over 150 years, we have focused on innovation and quality in eye care products, from contact lenses and solutions to eye drops, ointments, eye vitamins ...

Bausch + Lomb saw a broad-based growth across its three core segments. Vision care, its largest, saw revenue rise 9% to $723 million, while surgical increased 13% to $231 million. Pharmaceuticals rose ...

Helps creat a fluid stream to direct the solution into the affected areas. To guarantee sterility, each bottle is single use only Eye wash soltion helps to clear eyes of foregin material such as ...

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb ( BLCO) chairman ...

Emergent appoints former Bausch + Lomb CEO to head company February 21, 2024 The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that closely ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an ...

Elios Vision former chairman and CEO Elliot Friedman said: “Bausch + Lomb’s extensive reach in cataract surgery will introduce ELIOS to a broader range of eye care professionals and help ...